I want to start a list of 100 ways any reasonable person would know not to buy RDGL. Yes, for sure, that is one of them!
The truth is, they only want to look for positives in these pinhead execs backgrounds, and discount or ignore anything negative. There is no true due diligence by OTC "investors". But, there is a price for doing this, and it's coming!
If anyone actually cared to deep dive into the background of this "company" they would see a list of nonsense with people who have zero background in anything even remotely related to this medical area.
And yet, this is basically the formula for just about every OTC ticker.
One of their major competitors was founded by an actual surgeon oncologist. And yet, they are nowhere near the OTC trying to "raise funds."
It's not a coincidence that this ticker got pumped up right after Korenko said he was "selling shares." It certainly doesn't look good when your ticker is at 6 cents, and you are trying to scam investors for 8 cents a share. 🤣